TABLE 2.
Summary of Cases Presented to our IBD Unit in April and May 2020
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
|---|---|---|---|---|---|
| Type of IBD | CD | CD | CD | CD | Left-sided UC |
| Sex | F | M | M | M | M |
| Medical therapy | Adalimumab (maintenance) | 5-ASA, prednisolone, and azathioprine | Adalimumab (maintenance) | Infliximab (maintenance) | 5-ASA, prednisolone, and azathioprine |
| History of bowel surgery | No | Yes | Yes | No | Yes |
| C/P | Symptom free | Abdominal pain and purulent discharge | Abdominal pain, diarrhea, and purulent discharge | Abdominal pain and purulent discharge | Bloody diarrhea (steroid resistant UC) |
| Cause of presentation | Maintenance dose of adalimumab | Fistulizing CD Right iliac fossa abscess |
Fistulizing CD Left iliac fossa abscess |
Fistulizing CD Right iliac fossa collection |
Loading dose of adalimumab |
| Hospitalization | No | Yes | Yes | Yes | No |
| Case 6 | Case 7 | Case 8 | Case 9 | Cases 10 and 11 | |
| Type of IBD | Extensive UC | Extensive UC | Extensive UC | UC (pancolitis) | Left sided UC (10) ulcerative proctitis (11) |
| Sex | F | F | F | F | F |
| Medical therapy | 5-ASA, prednisolone, and azathioprine | Adalimumab (maintenance) | Adalimumab (maintenance) | 5-ASA and azathioprine | 5-ASA |
| History of bowel surgery | No | No | No | No | No |
| C/P | Bleeding per rectum and abdominal pain (steroid-dependent UC) | Mild abdominal pain | Symptom free | Bleeding per rectum (dependent UC) | Fever with dry cough No GIT related symptoms |
| Cause of presentation | Loading dose of infliximab | Maintenance dose of adalimumab | Maintenance dose of adalimumab | Loading dose of infliximab | Suspicion of IBD activity. Exclusion of COVID-19 infection (swab result was positive) |
| Hospitalization | No | No | No | No | The patients were admitted to an isolation hospital) |